Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Biomaterials|November 1, 2012
A gold nanoparticle platform for the delivery of functional microRNAs into cancer cellsRajib Ghosh, Lalithya C Singh, Jason M Shohet, et al.Cancer Research|March 17, 2007
MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cellsAndrew D Slack, Zaowen Chen, Andrew D Ludwig, et al.Proceedings of the National Academy of Sciences of the United States of America|January 13, 2005
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastomaAndrew Slack, Zaowen Chen, Roberto Tonelli, et al.Molecular Cancer Therapeutics|September 21, 2006
MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell deathEveline Barbieri, Parth Mehta, Zaowen Chen, et al.Neoplasia (New York, N.Y.)|August 4, 2009
Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivoZaowen Chen, Yunfu Lin, Eveline Barbieri, et al.Molecular Cancer Therapeutics|April 26, 2024
Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and MetastasisEsteban J Rozen, William Frantz, Kim Wigglesworth, et al.Oncotarget|March 20, 2016
Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastomaSaurabh Agarwal, Rajib Ghosh, Zaowen Chen, et al.Cancer Research|April 25, 2015
G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell ActivationSaurabh Agarwal, Anna Lakoma, Zaowen Chen, et al.Current Drug Targets|January 7, 2014
MDM2-p53 interaction in paediatric solid tumours: preclinical rationale, biomarkers and resistanceGiuseppe Barone, Deborah A Tweddle, Jason M Shohet, et al.Oncotarget|May 15, 2018
MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastomaSaurabh Agarwal, Giorgio Milazzo, Kimal Rajapakshe, et al.Pageof 4